4//SEC Filing
Wong Amy 4
Accession 0001209191-23-047441
CIK 0001814140other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:20 PM ET
Size
32.0 KB
Accession
0001209191-23-047441
Insider Transaction Report
Form 4
Apexigen, Inc.APGN
Wong Amy
SVP, Finance and Operations
Transactions
- Tax Payment
Common Stock
2023-08-23$0.39/sh−15,561$5,993→ 66,565 total - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−15,367→ 0 totalExercise: $2.25Exp: 2026-12-16→ Common Stock (15,367 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−28,685→ 0 totalExercise: $4.59Exp: 2029-02-14→ Common Stock (28,685 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−15,366→ 0 totalExercise: $4.59Exp: 2031-02-12→ Common Stock (15,366 underlying) - Disposition to Issuer
Common Stock
2023-08-23−66,565→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−22,333→ 0 totalExercise: $1.27Exp: 2024-05-09→ Common Stock (22,333 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−8,708→ 0 totalExercise: $1.47Exp: 2025-06-25→ Common Stock (8,708 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−230,507→ 0 totalExercise: $1.66Exp: 2025-10-30→ Common Stock (230,507 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−13,830→ 0 totalExercise: $2.25Exp: 2027-02-17→ Common Stock (13,830 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−71,159→ 0 totalExercise: $3.62Exp: 2028-05-22→ Common Stock (71,159 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−25,611→ 0 totalExercise: $4.59Exp: 2030-02-20→ Common Stock (25,611 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2023-08-23−76,800→ 0 totalExercise: $2.46Exp: 2032-10-07→ Common Stock (76,800 underlying)
Footnotes (12)
- [F1]The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
- [F10]The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2020. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 4,417 shares of Pyxis common stock at an exercise price of $26.61 per share.
- [F11]The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2021. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,649 shares of Pyxis common stock at an exercise price of $26.61 per share.
- [F12]The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2022. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 13,248 shares of Pyxis common stock at an exercise price of $14.27 per share.
- [F2]Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the "Merger Agreement"), by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), each share of Issuer common stock was exchanged for 0.1725 shares of Pyxis common stock and rounded down to the nearest whole share.
- [F3]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 3,852 shares of Pyxis common stock at an exercise price of $7.37 per share.
- [F4]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 1,502 shares of Pyxis common stock at an exercise price of $8.53 per share.
- [F5]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 39,761 shares of Pyxis common stock at an exercise price of $9.63 per share.
- [F6]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,650 shares of Pyxis common stock at an exercise price of $13.05 per share.
- [F7]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 2,385 shares of Pyxis common stock at an exercise price of $13.05 per share.
- [F8]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 12,274 shares of Pyxis common stock at an exercise price of $20.99 per share.
- [F9]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 4,947 shares of Pyxis common stock at an exercise price of $26.61 per share.
Documents
Issuer
Apexigen, Inc.
CIK 0001814140
Entity typeother
Related Parties
1- filerCIK 0001940217
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:20 PM ET
- Size
- 32.0 KB